NRx Pharmaceuticals (NASDAQ:NRXP) Announces Data-Lock of Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression
Stock Information for NRX Pharmaceuticals Inc.
Loading
Please wait while we load your information from QuoteMedia.